+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032- Product Image
Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032- Product Image
Sale

Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337448
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Subcutaneous Insulin Infusion Market is projected to reach USD 901.62 Million in 2026. It is expected to continue growing at a CAGR of 10.42%, reaching USD 1.64 Billion by 2032.

Continuous Subcutaneous Insulin Infusion (CSII), commonly known as insulin pump therapy, is moving from a specialist diabetes intervention to a core pillar of technology-enabled diabetes management. CSII delivers rapid-acting insulin through programmable basal rates and bolus dosing, helping people with type 1 diabetes and selected insulin-requiring type 2 diabetes populations manage glycemic variability with greater precision than conventional injection schedules.

Market momentum is supported by the rising global diabetes burden, broader use of continuous glucose monitoring (CGM), and clinical demand for automated insulin delivery systems. The World Health Organization reports that the number of people living with diabetes increased from 200 million in 1990 to 830 million in 2022, underscoring the long-term need for scalable, evidence-based insulin delivery solutions. Clinical guidelines increasingly recognize insulin pump therapy and CGM-integrated care as important options for improving time-in-range, reducing hypoglycemia risk, and supporting individualized diabetes treatment.

Transformative Shifts in CSII and Automated Insulin Delivery

The CSII landscape is being reshaped by the convergence of insulin pumps, CGM sensors, mobile applications, and algorithm-driven dosing support. Tubed pumps continue to serve patients needing highly customizable programming, while patch pumps are expanding appeal through discreet wearability and simplified user experience. Interoperable pump platforms are also changing procurement decisions by allowing compatible components to work within broader digital diabetes ecosystems.

Regulatory pathways and payer expectations are shifting toward demonstrable outcomes, usability, cybersecurity, and real-world evidence. Hybrid closed-loop systems, first cleared in the United States in 2016, accelerated the transition from manual pump therapy to automated insulin delivery, making time-in-range, hypoglycemia reduction, infusion set performance, device reliability, and patient-reported burden key competitive indicators.

Cumulative Impact of AI on Insulin Pump Therapy

Artificial intelligence is adding cumulative value across CSII by improving glucose forecasting, pattern recognition, remote monitoring, and clinical decision support. AI-enabled analytics can identify recurring hyperglycemia, nocturnal hypoglycemia risk, missed boluses, and insulin sensitivity changes, helping clinicians personalize pump settings more efficiently while supporting patients between clinic visits.

The most defensible AI opportunity is not fully autonomous care, but safer, explainable augmentation of insulin therapy. Industry leaders must align AI models with regulatory expectations for software as a medical device, protect sensitive health data, validate performance across diverse populations, and maintain transparent human oversight in dosing-related recommendations. As automated insulin delivery expands, AI will be most valuable when it strengthens safety, usability, adherence, and clinically validated personalization rather than replacing clinician judgment.

Key Regional Insights Across CSII Adoption

North America remains a leading CSII adoption region due to mature endocrinology networks, established reimbursement pathways, high CGM penetration, and early regulatory acceptance of automated insulin delivery. The United States is particularly influential because cleared pumps, CGMs, and interoperable systems often set reference points for global commercialization and clinical evidence expectations, while Canada’s provincial reimbursement models create structured but variable access to insulin pump therapy.

Europe benefits from strong diabetes care infrastructure, national health systems, and procurement models that increasingly evaluate quality-adjusted outcomes, device usability, safety, and long-term clinical value. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia improve diabetes technology access, although affordability, specialist availability, diabetes education, and reimbursement depth remain uneven. Latin America shows demand growth in urban private healthcare systems, especially where specialist diabetes care and CGM use are increasing, while public-sector access remains constrained. The Middle East is supported by high diabetes prevalence, premium hospital investment, and national noncommunicable disease strategies, particularly in higher-income Gulf countries. Africa remains earlier stage, with CSII access shaped by insulin affordability, supply continuity, limited reimbursement for advanced diabetes devices, and uneven availability of trained endocrinology teams.

Key Group Insights for CSII Stakeholders

G7 markets anchor global CSII innovation through advanced reimbursement systems, established diabetes technology pathways, clinical trial activity, and early adoption of CGM-integrated pump therapy. The European Union adds scale through harmonized medical device regulation under the Medical Device Regulation framework, while national reimbursement decisions continue to determine patient access, procurement speed, and clinical uptake across member states.

BRICS countries represent long-term adoption potential because of large diabetes populations, expanding middle-class healthcare demand, and growing digital health infrastructure, but pricing, distribution, import dependency, and clinician training are decisive adoption factors. ASEAN markets are heterogeneous, with higher-income and urban centers demonstrating stronger private-sector uptake than lower-income settings where diabetes technology reimbursement is limited. GCC countries benefit from high healthcare spending, diabetes-focused public health strategies, and investment in specialist care, supporting interest in insulin pumps and automated insulin delivery. NATO membership is less directly tied to CSII demand, but overlapping North American and European healthcare, defense-health, and procurement standards reinforce cybersecurity, supply resilience, data protection, and device quality expectations for connected diabetes technologies.

Key Country Insights in CSII Markets

The United States is the most influential CSII country market, supported by advanced pump portfolios, CGM integration, telehealth-enabled endocrinology, established device clearance pathways, and strong patient advocacy. Canada follows with structured provincial reimbursement variation, while Mexico and Brazil show expanding private-market demand alongside public access constraints and uneven specialist availability. The United Kingdom, Germany, France, Italy, and Spain rely on guideline-led diabetes care, health technology assessment, and reimbursement evaluation, though access speed differs by payer, region, and clinical eligibility criteria. Russia faces a more constrained environment due to procurement complexity, reimbursement limitations, and technology supply considerations.

China and India provide substantial long-term adoption opportunities because of their large diabetes populations, but affordability, awareness, reimbursement development, and specialist capacity strongly influence insulin pump uptake. Japan, South Korea, and Australia show stronger readiness for automated insulin delivery because of advanced clinical infrastructure, high digital health maturity, established diabetes care pathways, and reimbursement or subsidy mechanisms for selected diabetes technologies. Across these countries, the strongest CSII adoption conditions occur where CGM access, pump training, endocrinology capacity, patient education, and payer recognition of outcomes such as time-in-range align within routine diabetes care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable, patient-centered CSII platforms that integrate pumps, CGMs, dosing algorithms, mobile connectivity, and secure cloud analytics. Competitive advantage will come from reducing training burden, improving infusion set reliability, extending wear time where clinically validated, simplifying onboarding, and demonstrating measurable outcomes such as increased time-in-range, reduced severe hypoglycemia, and lower diabetes management burden.

Manufacturers and healthcare stakeholders should expand real-world evidence programs, localize affordability strategies, and invest in clinician education for pump initiation, data interpretation, and troubleshooting. Partnerships with payers, diabetes clinics, pharmacies, advocacy groups, and digital health providers can accelerate adoption while ensuring cybersecurity, post-market surveillance, software update governance, and equitable access remain central to commercialization. Leaders should also design region-specific pathways that address reimbursement requirements, local clinical guidelines, language needs, supply continuity, and patient support infrastructure.

Research Methodology

This executive assessment applies a triangulated research methodology combining verified secondary sources, regulatory databases, peer-reviewed clinical literature, public health datasets, reimbursement policies, product labeling, medical device clearance records, and diabetes care guidelines. Sources are evaluated for credibility, recency, geographic relevance, methodological transparency, and consistency with established clinical and regulatory evidence.

Insights are strengthened through market mapping across device types, end-user settings, reimbursement environments, regional access conditions, clinical adoption barriers, and technology readiness. Findings are interpreted using evidence-based analysis of clinical utility, regulatory feasibility, adoption barriers, competitive positioning, patient usability, cybersecurity considerations, and long-term demand drivers in CSII and automated insulin delivery. No market sizing, market share, or forecasting assumptions are used in this assessment.

Conclusion

CSII is entering a new phase defined by automation, interoperability, AI-assisted personalization, and outcomes-based access expectations. As diabetes prevalence continues to rise globally, insulin pump therapy is positioned to play a larger role in improving glycemic management, reducing patient burden, and supporting data-driven clinical care across type 1 diabetes and selected insulin-requiring type 2 diabetes populations.

The strongest opportunities will favor organizations that combine clinically validated technology with affordability, cybersecurity, usability, regulatory readiness, and regional access strategies. Stakeholders that can translate innovation into trusted, reimbursable, and scalable diabetes care solutions will be best positioned in the evolving CSII ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Continuous Subcutaneous Insulin Infusion Market, by Product Type
7.1. Introduction
7.2. Insulin Pumps
7.2.1. Tethered Pumps
7.2.2. Patch pumps
7.3. Pump Accessories
7.3.1. Infusion sets
7.3.2. Batteries
7.3.3. Reservoirs
7.3.4. Patches
7.4. CSII Software & Digital Platforms
7.4.1. Remote Monitoring App
7.4.2. Data Management & Analytics Platforms
7.4.3. Automated Insulin Delivery
8. Continuous Subcutaneous Insulin Infusion Market, by Insulin Type
8.1. Introduction
8.2. Rapid Acting Analog
8.3. Regular Insulin
8.4. Short Acting
9. Continuous Subcutaneous Insulin Infusion Market, by Technology Type
9.1. Introduction
9.2. Conventional Insulin Pumps
9.3. Sensor-Augmented Pumps
9.4. Advanced Closed-Loop Systems
10. Continuous Subcutaneous Insulin Infusion Market, by Age Group
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Continuous Subcutaneous Insulin Infusion Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.3. Homecare
11.4. Hospitals
11.5. Diabetes clinic
12. Continuous Subcutaneous Insulin Infusion Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Continuous Subcutaneous Insulin Infusion Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Continuous Subcutaneous Insulin Infusion Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. B. Braun SE
16.2. Baxter International, Inc.
16.3. Becton, Dickinson and Company
16.4. Bigfoot Biomedical, Inc.
16.5. BPL Medical Technologies Private Limited
16.6. CeQur SA
16.7. F. Hoffmann-La Roche Ltd.
16.8. Forbion
16.9. Fresenius SE & Co. KGaA
16.10. Insulet Corporation
16.11. MannKind Corporation
16.12. Medtronic PLC
16.13. MicroPort Scientific Corporation
16.14. Nipro Corporation
16.15. Pharmasense AG
16.16. Sanofi S.A.
16.17. Shinmyung Mediyes CO., LTD.
16.18. SOOIL Developments Co., Ltd.
16.19. Tandem Diabetes Care, Inc.
16.20. Terumo Group
16.21. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL TETHERED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL TETHERED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL TETHERED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PATCH PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PATCH PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PATCH PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PUMP ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PUMP ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PUMP ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INFUSION SETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INFUSION SETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INFUSION SETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BATTERIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BATTERIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BATTERIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL RESERVOIRS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RESERVOIRS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RESERVOIRS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CSII SOFTWARE & DIGITAL PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CSII SOFTWARE & DIGITAL PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CSII SOFTWARE & DIGITAL PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL REMOTE MONITORING APP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL REMOTE MONITORING APP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL REMOTE MONITORING APP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DATA MANAGEMENT & ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DATA MANAGEMENT & ANALYTICS PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DATA MANAGEMENT & ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL RAPID ACTING ANALOG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL RAPID ACTING ANALOG MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL RAPID ACTING ANALOG MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL REGULAR INSULIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL REGULAR INSULIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL REGULAR INSULIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SHORT ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SHORT ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SHORT ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SENSOR-AUGMENTED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SENSOR-AUGMENTED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SENSOR-AUGMENTED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ADVANCED CLOSED-LOOP SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ADVANCED CLOSED-LOOP SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ADVANCED CLOSED-LOOP SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIABETES CLINIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DIABETES CLINIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIABETES CLINIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 95. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 96. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 97. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 98. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 99. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 100. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 101. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 123. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 124. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 125. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 126. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 127. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 128. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 142. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 143. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 144. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 145. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 146. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 147. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 151. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 152. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 153. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 154. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 155. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 156. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 160. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 161. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 162. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 163. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 164. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 165. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 178. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 179. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 180. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 181. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 182. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 183. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 187. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 188. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 189. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 190. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 191. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 192. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 194. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 195. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 196. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 197. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 198. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 199. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 200. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 201. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 202. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 215. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 216. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 217. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 218. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 219. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 220. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 222. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 223. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 224. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 225. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 226. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 227. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 228. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 229. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 233. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 234. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 235. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 236. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 237. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 238. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 251. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 260. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 261. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 262. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 263. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 264. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 265. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 269. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 271. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 272. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 273. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 274. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 278. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 279. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 280. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 281. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 282. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 283. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 287. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 288. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 289. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 290. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 291. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 292. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLATFORMS, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PUMP ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CSII SOFTWARE & DIGITAL PLA

Companies Mentioned

  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • BPL Medical Technologies Private Limited
  • CeQur SA
  • F. Hoffmann-La Roche Ltd.
  • Forbion
  • Fresenius SE & Co. KGaA
  • Insulet Corporation
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Pharmasense AG
  • Sanofi S.A.
  • Shinmyung Mediyes CO., LTD.
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Terumo Group
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 901.62 Million
Forecasted Market Value ( USD ) by 2032 $ 1640 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Insulin Infusion Pump Market Report 2026 - Product Image

Insulin Infusion Pump Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Insulin Pumps Market - Global Forecast 2026-2032 - Product Image

Insulin Pumps Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Insulin Pumps Market Report by Product Type, Distribution Channel, and Region 2026-2034 - Product Image

Insulin Pumps Market Report by Product Type, Distribution Channel, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Human Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Human Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Glucose Responsive Insulin System Market - Global Forecast 2025-2032 - Product Image

Glucose Responsive Insulin System Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.